Tissue Solutions is Expanding - Clinical Trials Arena
Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here

Tissue Solutions is Expanding

26th September 2011

Tissue Solutions is delighted to announce the appointment of Simon Goulding as a consulting finance director to the business and to welcome two new members of staff to the business development team.

Simon has held a number of high profile finance positions, including chief operating officer at Campbell Dallas, head of finance and administration at Blandy & Blandy and finance manager at Deloitte Consulting. While at Campbell Dallas, an accountancy firm with fees of £10m and 150 staff, he was responsible for the support functions with five direct reports in finance, HR, IT, marketing and facilities managers. Simon will be responsible for the finance function at Tissue Solutions.

Dr Morag McFarlane, chief scientific officer, said: "I am delighted to announce Simon’s appointment. He brings with him a wealth of financial experience in high profile roles and his proven track record will consolidate and further strengthen Tissue Solutions’ growth at this exciting time in the company’s development."

The business development team is also set to expand with the addition of two new members of staff. Stuart Richards joins as an assistant business development graduate and Mark Munro as business development manager.

Stuart has a strong background in life sciences and studied for an MRes in biomedical sciences from Strathclyde University where he investigated the anti-inflammatory properties of Lovage (Levisticum Officinale). He has taken courses in immunology, and ethics and legal aspects in research. He will support the team in its business activities and help in building strong customer relationships.

Mark joins from UCB Pharma where he worked as a senior product specialist. He has over fifteen years’ experience in sales and marketing in the pharmaceutical industry and a proven track record in sales and account management. Mark will work closely with the CSO and COO to help implement new strategies for business growth and develop the external customer base.

Commenting, Dr Ann Cooreman said: "These appointments demonstrate our continued commitment to the expansion and development of the company. We have seen turnover increase by 50% for the second consecutive year and are now in a position to recruit new staff to support this growth."

All of the new members of the team will start at the end of September.

More About This Company